• Home

  • News
    • Colorado
    • California
    • US News
    • World News
    • Politics
    • Business
    • Crime
    • Year in Review
      • 2016
      • 2015
      • 2014
    • The Denver Post
  • Culture
    • Entertainment
    • Calendar / Upcoming Events
    • Sports
    • Style
    • Interviews
    • Pot and Parenting
    • US Culture
    • World Culture
    • High Minded podcast by The Cannabist
    • The Cannabist Show
    • All Things 4/20
  • Reviews
    • Strain Reviews
    • Vaporizer & Product Reviews
    • Gone Hemp
  • Food
    • Cannabis Recipes
      • Appetizers
      • Entrees
      • Desserts
      • Beverages
      • Holidays & Gift Ideas
    • How-to: Cannabutter & Canna-oil
  • Resources
    • Where is Weed Legal? (map)
    • Ask The Cannabist
    • Cultivation Tips and Advice
    • Pot and the Body
  • Map

Topic: Insys Therapeutics

DEA finalizing Schedule II status for synthetic THC drug Syndros

  • Pharma CEO who funded anti-cannabis campaign accused of giving docs kickbacks to prescribe opioids

  • New Jersey sues painkiller company, calling its methods “evil”

  • Synthetic THC drug Syndros poised for Schedule II classification

  • The non-weed biz world is zeroing in on legalization

  • A casino magnate’s spending millions against pot. Here’s who’s also donating for (and against) legalization

  • Biz owners replace idealists in pro-pot movement

  • Is a maker of deadly painkillers bankrolling the opposition of Arizona marijuana legalization?

Find A Store Near You

Follow Us

  • Follow The Cannabist on Twitter
  • Like The Cannabist on Facebook
  • Follow The Cannabist on Instagram
  • Follow The Cannabist via RSS

The Cannabist Calendar

  • About
  • Contact
  • Ethics Policy
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Advertise

An edition of The Denver Post. All contents Copyright © 2022 The Denver Post or other copyright holders | Powered by WordPress.
All rights reserved. This material may not be published, broadcast, rewritten or redistributed for any commercial purpose.